Conduramine F-1 epoxides: synthesis and their glycosidase inhibitory activities

被引:16
作者
Lysek, Robert [1 ]
Favre, Sylvain [1 ]
Vogel, Pierre [1 ]
机构
[1] Ecole Polytech Fed Lausanne, Lab Glycochim & Synthes Asymetriq LGSA, CH-1015 Lausanne, Switzerland
关键词
D O I
10.1016/j.tet.2007.03.149
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Starting from (+/-)-7-oxanorbornenone ((+/-)-14), (+/-)-(1RS, 2RS, 3SR, 6SR)-6-azidocyclohex-4-en-1,2,3-triol ((+/-)-24) and (+/-)- 1RS, 2RS, 3SR, 6RS)-6-azidocyclohex-4-en-1,2,3-triol ((+/-)-26) were obtained. Epoxidation of the latter cyclohexene derivative gave two epoxides (+/-)-30 and (+/-)-31 that were converted into (+/-)-conduramine F-1 epoxides (+/-)-10 and (epoxides (+/-)-30 and (+/-)-31 that were converted into (+/-)-conduramine F-1 epoxides (+/-)-10 and (+/-)-11 and N-substituted derivatives (+/-)-12 and (+/-)-13. Compound (+/-)-(1RS, 2SR, 3RS, 4SR, 5RS, 6SR)-5-({[4-(trifluoromethyl) phenyl] methyl} amino)-7-oxabicyclo[4.1.0]heptane-2,3,4- triol ((+/-)-12c) is a good, non-competitive inhibitor of beta-xylosidase from Aspergillus niger (K-i=2.2 mu M), and (+/-)( 1RS, 2RS, 3SR, 4RS, 5SR, 6SR)-5-{[(biphenyl-4-yl) methyl] amino}-7-oxabicyclo[4.1.0] heptane-2,3,4-triol ((+/-)-13d) is a good inhibitor of alpha-glucosidase from brewer's yeast (Ki 2.8 mu M, non-competitive). (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6558 / 6572
页数:15
相关论文
共 134 条
[1]   The synthetic development of the anti-influenza neuraminidase inhibitor oseltamivir phosphate (Tamiflu®):: A challenge for synthesis & process research [J].
Abrecht, S ;
Harrington, P ;
Iding, H ;
Karpf, M ;
Trussardi, R ;
Wirz, B ;
Zutter, U .
CHIMIA, 2004, 58 (09) :621-629
[2]   Strategies to prevent type 2 diabetes [J].
Abuissa, H ;
Bell, DSH ;
O'Keefe, JH .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (07) :1107-1114
[3]   Cotranslational membrane protein biogenesis at the endoplasmic reticulum [J].
Alder, NN ;
Johnson, AE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (22) :22787-22790
[4]  
Arnold SM, 2003, N COMP BIOC, V38, P411
[5]   In vitro inhibition and intracellular enhancement of lysosomal α-galactosidase A activity in Fabry lymphoblasts by 1-deoxygalactonojirimycin and its derivatives [J].
Asano, N ;
Ishii, S ;
Kizu, H ;
Ikeda, K ;
Yasuda, K ;
Kato, A ;
Martin, OR ;
Fan, JQ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (13) :4179-4186
[6]   Glycosidase inhibitors: update and perspectives on practical use [J].
Asano, N .
GLYCOBIOLOGY, 2003, 13 (10) :93R-104R
[7]   Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application [J].
Asano, N ;
Nash, RJ ;
Molyneux, RJ ;
Fleet, GWJ .
TETRAHEDRON-ASYMMETRY, 2000, 11 (08) :1645-1680
[8]   BIOLOGICAL-ACTIVITIES OF CYCLOPHELLITOL [J].
ATSUMI, S ;
IINUMA, H ;
NOSAKA, C ;
UMEZAWA, K .
JOURNAL OF ANTIBIOTICS, 1990, 43 (12) :1579-1585
[9]   Oseltamivir [J].
Bardsley-Elliot, A ;
Noble, S .
DRUGS, 1999, 58 (05) :851-860
[10]   REDUCTION OF AZIDES TO AMINES BY SAMARIUM DIIODIDE [J].
BENATI, L ;
MONTEVECCHI, PC ;
NANNI, D ;
SPAGNOLO, P ;
VOLTA, M .
TETRAHEDRON LETTERS, 1995, 36 (40) :7313-7314